Course Directors: C. Scott Collins, M.D., DeLisa Fairweather, Ph.D., Michael J. Joyner, M.D., Paschalis Vergidis, M.D. and R. Scott Wright, M.D.

These recordings of the February 26, 2022, livestream event sought to educate and update clinicians, researchers, healthcare executives, and policy makers on the current state of therapeutic options for COVID-19 in 2022.  This course focused on the evolving utility of and data supporting the use of convalescent plasma in COVID-19 patients.  The current regulatory framework and expanded access program were discussed.  In addition, indications, advances in, and appropriate candidates for monoclonal antibody therapy for at risk patients were reviewed.  The steps to build and manage the infusion program designed to treat the local area surrounding Mayo Clinic were highlighted.  Finally, a review of the latest data regarding the safety, efficacy, and future directions of vaccination for COVID-19 prevention was given.

February 26, 2022 Livestream Recordings
COVID-19 Convalescent Plasma – Early 2022 Update (PDF) 
Arturo Casadevall, MD, PhD
Exciting Biological Insights and Findings (PDF) 
DeLisa Fairweather, PhD
Update on the Prevention and Treatment of COVID-19 with Monoclonal Antibodies (PDF)
Paschalis Vergidis, MD
Implementing an Infusion Program at your Medical Center – Pearls and Pitfalls (PDF) 
Ravindra Ganesh, MBBS, MD
Panel Questions & Discussion
Moderators: Katelyn A. Bruno, PhD and Jonathon (Jack) W. Senefeld, PhD
Vaccine Updates – Current Science (PDF) 
Gregory A. Poland, MD
Vaccines and the Product Regulatory Landscape (PDF) 
Peter Marks, MD
Innovative Data Strategies – Tried and True & New and Promising (PDF)
Rickey Carter, PhD
WHO or Not WHO – Insights for the Future of CCP-19 (PDF) 
Mike Joyner, MD

Panel Questions & Discussion
Moderators: Katelyn A. Bruno, PhD and Jonathon (Jack) W. Senefeld, PhD